Posts

Showing posts with the label Pneumonia Testing Market

Pneumonia Testing Market Size to Hit USD 912.5 Million

 The global  pneumonia testing market  size hit  USD 557.1 million in 2021 . The market valuation is slated to rise from  USD 606.6 million in 2022  to  USD 912.5 million by 2029 , recording  6% CAGR   during 2022-2029 . This information is provided by Fortune Business Insights in its report titled  “Pneumonia Testing Market, 2022-2029” . Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pneumonia-testing-market-106787 Regional Insights :       The North American Market Stood at USD 221.4 Million in 2021 North America dominated the pneumonia testing market share in 2021 with USD 221.4 million. The region will continue to hold the dominant market share through 2029 led by growing pneumonia cases, rapid adoption of point-of-care technologies, and supportive reimbursement policies. The European market holds the second-larges...

Pneumonia Testing Market Size to Hit USD 912.5 Million by 2029

The global  pneumonia testing market  size hit  USD 557.1 million in 2021 . The market valuation is slated to rise from  USD 606.6 million in 2022  to  USD 912.5 million by 2029 , recording  6% CAGR   during 2022-2029 . This information is provided by Fortune Business Insights in its report titled  “Pneumonia Testing Market, 2022-2029” . Key Industry Development: April 2022:  bioMérieux SA acquired Specific Diagnostics, a company that developed a rapid Antimicrobial Susceptibility Test (AST) system that directly delivers phenotypic AST from positive blood cultures. Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pneumonia-testing-market-106787 Regional Insights :       The North American Market Stood at USD 221.4 Million in 2021 North America dominated the pneumonia testing market share in 2021 with USD 221.4 millio...